Effects of Body Mass and Age on the Pharmacokinetics of Subcutaneous or Hyaluronidase-facilitated Subcutaneous Immunoglobulin G in Primary Immunodeficiency Diseases

PURPOSE: To assess the pharmacokinetics (PK) of subcutaneous immunoglobulin (SCIG) and hyaluronidase-facilitated SCIG (fSCIG) therapy across body mass index (BMI) and age categories in patients with primary immunodeficiency diseases (PIDD) previously treated with intravenous immunoglobulin (IVIG). M...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Zhaoyang, Follman, Kristin, Freshwater, Ed, Engler, Frank, Yel, Leman
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10661727/
https://www.ncbi.nlm.nih.gov/pubmed/37773562
http://dx.doi.org/10.1007/s10875-023-01572-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10661727/
https://www.ncbi.nlm.nih.gov/pubmed/37773562
http://dx.doi.org/10.1007/s10875-023-01572-x

Ejemplares similares